Concepedia

Sendogan Aker

SA

Statistics

Publications

13

Citations

814

H-Index

13

Active since

1998

Affiliations

Heinrich Heine University Düsseldorf(Current)

Evangelisches Krankenhaus Mettmann

University of Oxford

Sendogan Aker is an author at Heinrich Heine University Düsseldorf specializing in medicine, nephrology, and renal disease.

Publications per year

1998–2023

13

Publications

13

Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis

Michael Koch, M. Kohnle, R. Trapp et al. · Nephrology Dialysis Transplantation · 2011 · 128 citations

, , +14

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Peritoneal Dialysis Relieves Clinical Symptoms and is Well Tolerated in Patients with Refractory Heart Failure and Chronic Kidney Disease

Michael Koch, Burkhard Haastert, M. Kohnle et al. · European Journal of Heart Failure · 2012 · 95 citations · Full text

, , +10

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

Cardiovascular risk factors and diseases after renal transplantation

Sendogan Aker, Katrin Ivens, B. Grabensee et al. · International Urology and Nephrology · 1998 · 75 citations

, , +14

1–5 of 13